| 1. | Exline MC, Crouser ED.Mitochondrial dysfunction during sepsis:still more questions than answers.Crit Care Med, 2011, 39:1216-1223. | 
				                                                        
				                                                            
				                                                                | 2. | Singer M.Mitochondrial function in sepsis:acute phase versus multiple organ failure.Crit Care Med, 2007, 35(9 Suppl):S441-S448. | 
				                                                        
				                                                            
				                                                                | 3. | Rocha M, Herance R, Rovira S, et al.Mitochondrial dysfunction and antioxidant therapy in sepsis.Infect Disord Drug Targets, 2012, 12:161-178. | 
				                                                        
				                                                            
				                                                                | 4. | Rittirsch D, Huber-Lang MS, Flierl MA, et al.Immunodesign of experimental sepsis by cecal ligation and puncture.Nat Protoc, 2009, 4:31-36. | 
				                                                        
				                                                            
				                                                                | 5. | Levy MM, Fink MP, Marshall JC, et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med, 2003, 31:1250-1256. | 
				                                                        
				                                                            
				                                                                | 6. | Levy RJ.Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis.Shock, 2007, 28:24-28. | 
				                                                        
				                                                            
				                                                                | 7. | Yorns WR Jr, Hardison HH.Mitochondrial dysfunction in migraine.Semin Pediatr Neurol, 2013, 20:188-193. | 
				                                                        
				                                                            
				                                                                | 8. | Boisrame-Helms J, Kremer H, Schini-Kerth V, et al.Endothelial dysfunction in sepsis.Curr Vasc Pharmacol, 2013, 11:150-160. | 
				                                                        
				                                                            
				                                                                | 9. | 黨曉燕, 秦勇, 丁新愛, 等.NT-proBNP、血小板及膽固醇水平與膿毒癥預后的相關性.臨床誤診誤治, 2013, 26:80-83. | 
				                                                        
				                                                            
				                                                                | 10. | Fink MP.Bench-to-bedside review:High-mobility group box 1 and critical illness.Crit Care, 2007, 11:229. | 
				                                                        
				                                                            
				                                                                | 11. | 陳昌勤, 張召才, 嚴靜.膿毒癥和心肌線粒體損傷.中國危重病急救醫學, 2007, 19:630-632. | 
				                                                        
				                                                            
				                                                                | 12. | 榮子杰, 楊聯軍, 朱立新, 等.氧化應激誘導髓核細胞凋亡中細胞內活性氧及線粒體膜電位的變化.實用醫學雜志, 2014, 30:193-195. | 
				                                                        
				                                                            
				                                                                | 13. | Brealey D, Brand M, Hargreav I, et al.Association between mitochondrial dysfunction and severity and outcome of septic shock.Lancet, 2002, 7:219-223. |